Implanet SA ALIMP
EURONEXT · France · Health Technology
€0.1580-0.00 (-2.59%)
Market open· · EUR · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · EUR · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
BORDEAUX, France & BOSTON, September 15, 2026--Regulatory News: IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME), a medical technology company specializing in implants for orthopedic surgery and in the distribution of advanced medical equipment, today announces its results for the first half of the current financial year, ended June 30, 2026, as approved by the Board of Directors on September 15, 2026.
BORDEAUX, France & MEMPHIS, Tenn., July 15, 2026--Regulatory News: IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for the PEA-PME scheme), a medical technology company specializing in spinal implants for orthopedic surgery and the distribution of advanced medical equipment, today announces the installation of 8i Robotics Inc.'s multi-arm surgical robot at Amiens-Picardie University Hospital, within the SimUSanté® Active Learning Simulation Center.
BORDEAUX, France & BOSTON, July 07, 2026--Regulatory News: IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME), a medical technology company specializing in implants for orthopedic surgery and the distribution of advanced medical equipment, today announces its revenue for the first half of 2026.
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.